Preview

Epilepsy and paroxysmal conditions

Advanced search

Experimental study of the anticonvulsant and psychotropic activities of pufemid, pyrathidine, and compound N3212 as compared with reference anti-epileptic drugs

https://doi.org/10.17749/2077-8333.2019.11.3.244-254.

Full Text:

Abstract

Aim: to study the anticonvulsant and psychotropic activities and side effects of pufemid, pyrathidine and compound N3012 developed at the Institute of Fine Organic Chemistry of the National Academy of Sciences.

Materials and methods. Anticonvulsant activities were tested using the following models of experimental seizures: maximum electric shock, corazol, camphor, thiosemicarbazide, picrotoxin, strychnine, amigdala-kindling convulsions. The psychotropic activities of the tested compounds were investigated using the “elevated plus maze”, “electroshock retrograde amnesia”, and the “open field” models. The neurotoxicity of the compounds was assessed by the level of impaired motor coordination in the “rotating rod” test and in the “grid climbing” test.

Results. Pufemid, pyrathidine, and compound N3212 demonstrated high anticonvulsant activity that was superior to the reference antiepileptic drugs; in addition, the tested compounds had low toxicity and high indicators of therapeutic and protective effects. Pufemid, pyrathidine and compound N3212 showed psychotropic activities: e. g., compound N3212 had anxiolytic and nootropic effects.

Conclusion. The tested compounds – pufemid, pyrathidine and compound N3212 – are highly efficient and low-toxic substances and are, therefore, promising for further preclinical and clinical studies as anti-epileptic drugs with psychotropic activities. 

About the Authors

R. G. Paronikyan
The Institute of fine organic chemistry named after A. L. Mnjoyan scientific-technological center of organic and pharmaceutical chemistry of NAS of Republic of Armenia
Armenia

PhD, Associate Professor, Senior Researcher,

26 Azatutyan Ave., Erevan 0014



M. N. Avagyan
Institute of Surgery Mikaelyan
Armenia

MD, PhD, Associate Professor, Head of the Department of Rehabilitation and Traditional Medicine,

9, Asratyan Str., Yerevan 0052



A. A. Harutyunyan
The Institute of fine organic chemistry named after A. L. Mnjoyan scientific-technological center of organic and pharmaceutical chemistry of NAS of Republic of Armenia
Armenia

PhD, Head of the Laboratory of Synthesis of Antitumor Compounds, Director of the Scientific and Technological Center of Organic and Pharmaceutical Chemistry,

26 Azatutyan Ave., Erevan 0014



G. G. Avakyan
Pirogov Russian National Research Medical University
Russian Federation

MD, PhD, Associate Professor, Department of Neurology, Neurosurgery and Medical Genetics,

1 Ostrovityanova Str., Moscow 117997



S. A. Litvinova
Zakusov Institute of Pharmacology
Russian Federation

Ph.D., Leading Researcher,

8 Baltijskaja Str., Moscow 125315



T. A. Voronina
Zakusov Institute of Pharmacology
Russian Federation

MD, PhD, Professor & Head, Laboratory of Psychopharmacology,

8 Baltijskaja Str., Moscow 125315



References

1. Paronikyan E.G., Oganesyan A.V., Paronikyan R.G., Dzhagatspanyan I.A. Nazaryan I.M., Akopyan A.G., Minasyan A.V. Synthesis and neurotropic activity of derivatives of 4-phenylpyridine-3-carboxylic acid and 4-hydroxy-4-phenylthieno [2,3-b] pyridine. Khimikofarmatsevticheskii zhurnal (in Russ). 2018; 52 (10): 22-27.

2. Babaev E.V., Koval’ Ya.I., Rybakov V.B., Paronikyan E.G., Stepanyan G.M., Paronikyan R.G., Dashyan Sh.Sh., Rzhevskii S.A., Shadrin I.A. 2-Allyloxy / propargyloxypyridines: synthesis, structure and biological activity. Izvestiya Akademii nauk. Seriya khimicheskaya (in Russ). 2018; 23: 313-320.

3. Pogosyan S.A., Grigoryan N.P., Paronikyan R.G. Synthesis and anticonvulsant activity of indoline dihydrochlorides (5’-bromindoline) -3’-spiro-1- (1,2,3,4-tetrahydro) -carboline and 3-methyl-β-carboline. Khimiko-farmatsevticheskii zhurnal (in Russ). 2011; 45 (8): 20-21.

4. Sirakanyan S.N., Geronikaki A., Spinelli Domenico, Paronikyan R.G., Dzhagatspanyan I.A., Nazaryan I.M., Akopyan A.H., Hovakimyan A.A. Pyridofuropyrrolo[1,2-a] pyrimidines and pyridofuropyrimido[1,2-a] azepines: new chemical entities (NCE) with anticonvulsive and psychotropic properties. RSC Advances. 2016; 6: 32234-32244.

5. Kazaryan S.A., Paronikyan R.G. Lithium and zinc derivatives of salicylidene amino acids as new neurotropic drugs. DNAN RA (in Russ). 2018; 118 (2): 160-165.

6. Mndzhoyan O.L., Avetisyan S. A., Akopyan N.E., Gerasimyan D.A., Dzhagatspanyan I.A., Pashinyan S.A. New domestic antiepileptic drug pufemide. Khimiko-farmatsevticheskii zhurnal (in Russ). 1983; 6: 757-761.

7. Dzhagatspanyan I.A, Paronikyan R.G., Nazaryan I.M., Akopyan A.G. Features of the psychotropic spectrum of action of some antiepileptic drugs. Meditsinskaya nauka v Armenii (in Russ). 2005; 4: 14-19.

8. Mashkovskii M. D. Medicines. Moscow. 2010; 1216 s.

9. USSR author’s certificate N3669489 / 166666 of 02/14/1984, B.I. RF N4. 1996; p. 266 (in Russ).

10. Dzhagatspanyan I.A., Paronikyan R.G., Nazaryan I.M. Experimental characteristics of the neurotropic spectrum of some antiepileptic drugs. Eksperimental’naya i klinicheskaya farmakologiya (in Russ). 2003; 6: 20-23.

11. Paronikyan R.G. Novel pyrimidine derivatives with anticonvulsant and psychotropic effects. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (3):39-46. (In Russ.) https://doi. org/10.17749/2077-8333.2017.9.3.040-046.

12. Guidelines for the maintenance and use of laboratory animals. Eighth edition. Translated from English. under the editorship of I. V. Belozertseva, D. V. Blinov, M. S. Krasilschikova. M.: IRBIS. 2017. (in Russ).

13. Swinyard E. A. in Experimental Models of Epilepsy, ed. D. P. Purpura, J. K. Penry, D. Tower, D. M. Woodbury and R. Walter, Raven Press, New-York. 1992; pp. 433-458.

14. Voronina T.A., Nerobkova L.N. Guidelines for the preclinical study of anticonvulsant activity of drugs, “ Guidelines for preclinical studies of drugs”. Moscow. 2012; Part 1. Chapter 14: pages 235-350 (in Russ).

15. Litvinova S.A., Voronina T.A., Kutepova I.S., Avdyunina N.I., Pyatin B.M. Issledovanie protivosudorozhnykh i protivogipoksicheskikh svoistv gemisuktsinata 2-etil-6-metil-3-gidroksipiridina. Eksperimental’naya i klinicheskaya farmakologiya (in Russ). 2018; 81 (3): 3-6.

16. Paxinoc G., Watson C. The Rat Brain. In: Stereotaxis Coordinates. 2-th ed. Sydney. 1986.

17. Voronina T.A., Seredenin S.B., Yarkova M.A. Guidelines for preclinical study of tranquilizing (anxiolytic) effects of drugs. “Guidelines for preclinical drug research.” Moscow. 2012; Part 1. Chapter 16: pp. 264-275. (in Russ).

18. Vogel H.G., Vogel W.H. Psychotropic and neurotropic activity. In: Drug Discovery and Evaluation: Pharmacological Assays, ed. H.E.Vogel, Springer. Berlin and N.Y. 2008; pp. 569-874.

19. Voronina T.A., Ostrovskaya R.U., Garibova T.L. Voronina T.A., Ostrovskaya R.U., Garibova T.L. Guidelines for preclinical study of drugs with nootropic type of action. “Guidelines for preclinical drug research.” M. 2012; Part 1. Chapter 17: pp. 276-296 (in Russ).

20. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficitin rats and mice. J.Am.Pharm. Ass. Sci. Ed. 1957; 46 (3): 208-209.


For citation:


Paronikyan R.G., Avagyan M.N., Harutyunyan A.A., Avakyan G.G., Litvinova S.A., Voronina T.A. Experimental study of the anticonvulsant and psychotropic activities of pufemid, pyrathidine, and compound N3212 as compared with reference anti-epileptic drugs. Epilepsy and paroxysmal conditions. 2019;11(3):244-254. (In Russ.) https://doi.org/10.17749/2077-8333.2019.11.3.244-254.

Views: 24


ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)